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Introduction:

- Autism Spectrum Disorder (ASD) is a developmental
disorder that is expected to affect 1 in 54 children in the
United States
- The etiologic agent for autism is unknown but scientists
suspect that environmental factors and genetics play a role.
- DEHP is a phthalate that is commonly used as a plasticizer in
PVC to make everyday consumer goods such as raingear,
shower curtains, and medical tubing more flexible.
- DEHP is an endocrine disrupting compound (EDC). EDC’s are
chemicals that interfere with the metabolic activities and
natural hormones in the body which are responsible for
homeostasis, reproduction, or development.
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Most studies did not take a sufficient number of urine samples to
adequately assess exposure
There was downgrading due to inconsistency in results across studies
while the other two studies showed no statistically significant effect.
All the evaluated studies suggested that prenatal supplements or folic
acid intake during pregnancy potentially have an attenuating effect on
social behavioral outcomes from DEHP exposure.

Study

Study Results
Type

Shin et al.
(2018)

Cohort

No increased risk for ASD with higher exposure to DEHP;
There was a sex dependent association between high
phthalate concentrations and non-typical development in
males.

Oulhote et al.
(2020)

Cohort

No observed association between gestational DEHP exposure
and higher SRS scores, which are correlated with non-typical
development.

Ponsonby et al. Cohort
(2020)

They found that infants with high phthalate levels, including
DEHP, were at moderate risk for an adverse neurological
outcome but that the risk was substantially elevated if infants
had a high gene score for oxidative stress and high phthalate
exposure.
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Objective

- To systematically review the literature published since 2014
to identify if there is an association between gestational
and/or early childhood DEHP exposure and Autism
incidence.
Participants: Children from 3-12 years old
Exposure: Children with high gestational or early childhood exposure to the
DEHP phthalate
Comparator: Children with low gestational or early childhood DEHP
phthalate exposure
Outcomes: Autism Spectrum Disorder
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Figure 1. Prisma Graphic showing study identification, screening,
eligibility and inclusion
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There was a high risk of bias across studies, specifically in the exposure assessment
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There was variability in the results; one study showed a potential protective effect of DEHP on ASD,
one showed no association, and the other showed moderate risk for adverse neurological outcomes.
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Conclusion and Recommendations

Following an extensive review of the literature I found four
studies that examined the potential influence of DEHP during
gestation and early childhood on Autism incidence
- Risk of bias of included studies was moderate
- This review shows potential evidence of DEHP exposure
influencing ASD incidence.
- Due to the different statistics used for summarizing results and
a lack of homogeneity between studies a meta-analysis could
not be performed.
- There was low quality of evidence found across studies and a
low number of studies included in review.
- The low-quality rating was driven primarily by poor exposure
assessments; specifically, most studies used an insufficient
number of urine samples to assess exposure which are likely
only reflective of the last 6-12 hours of exposure to DEHP.
- Future cohort studies need to account for the potential
variability in exposure across pregnancy and early childhood by
taking many urine samples and pooling.

